ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-Insured vs Motilal Oswal S&P BSE Healthcare ETF
NAV, returns and costs — not a recommendation.
 ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-Insured |  Motilal Oswal S&P BSE Healthcare ETF | |
|---|---|---|
| NAV | ₹43.43 | ₹51.5823 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +7.31% | +14.45% |
| 3 year (p.a.) | +22.09% | +22.35% |
| 5 year (p.a.) | +15.97% | +22.17% |
| Expense ratio | 1.56% | 0.25% |
| Fund size | ₹6,624.58 Cr | ₹39.76 Cr |
| Risk | Very high | Very high |
| Category | Sectoral Pharma and Healthcare | Etfs |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.